Menu
21 Jan 2020 | 11:33 PM
 

Aarti Drugs Ltd. Share Price Live (BSE)
0

BSE Code: 524348 | NSE Symbol: AARTIDRUGS
628.15
14.75
(2.41 %)
17 Jan 2020 | 10:51 AM
Change company
  • Open (Rs)
    618.25
  • Prev. close (Rs.)
    613.40
  • High (Rs.)
    635.00
  • Low (Rs.)
    616.30
  • 52W H (Rs.)
    705.00
  • 52W L (Rs.)
    419.30
  • Volume
    1167
  • MCap (Rs in Cr.)
    1,463.59
F&O Futures F&O Options
Expiry Date
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
38.06
Operating Margin (%)
13.28
Gross Profit Margin (%)
10.55
Net Profit Margin (%)
5.74
Total Debt/Equity
0.87
Dividend payout Ratio (Net Profit)
3.16
Earning Retention Ratio
96.84

News

Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30 2019
22 Oct 2019 - 17:20:00-As of September 2019 61.64% is owned by Indian Promoters and 38.36% by Public...
Aarti Drugs’ Consolidated Quarterly Revenue grows 8.32% in Q1 FY20
29 Jul 2019 - 16:04:00-Aarti Drugs Limited said that “In June quarter the company recorded the consolidated quarterly...
Aarti Drugs Ltd Q1 net profit down 3.66% at Rs 21.57 cr
26 Jul 2019 - 15:50:00-The company reported standalone net profit of Rs 21...
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2019
20 Jul 2019 - 16:30:00-As of June 2019 62.25% is owned by Indian Promoters and 37.75% by Public...

Announcements

07-Jan-2020
Aarti Drugs Ltd - Updates
07-Jan-2020
Aarti Drugs Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Jan-2020
Aarti Drugs Ltd - Acquisition
06-Jan-2020
Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Acquisition
31-Dec-2019
Aarti Drugs Ltd - Trading Window

Religare Research

Agri Fundamental & Technical Report
28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
Agri Fundamental & Technical Report
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
Weekly Report ( Metals & Energy) Jan 21-Jan 25 2019
21 Jan 2019 | 07:35 PM
Weekly report
Weekly Report ( Metals Energy ) 7th Jan 2019 11th Jan 2019
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
4,21,002 23.92 28.66 0.56
4,21,002 23.92 53.39 0.56
4,21,002 23.92 55.85 0.56
4,21,002 23.92 30.00 0.56
1,69,941 9.65 13.16 -0.48

Shareholding Pattern

       
Promotors61.64%
Mutual Funds/UTI4.18%
FI/Banks0.57%
Insurance0.57%
FII0.61%
Government0.00%
Others3.83%

Peer Group

Company Intraday Graph
 Hester Biosciences Ltd.
1,600.00(0.94)
 3572
 Fermenta Biotech Ltd.
867.00(0.53)
 3299
 Kovai Medical Center and Hospital Ltd.
740.05(-2.45)
 11816
 Novartis India Ltd.
663.05(0.09)
 2647

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Aarti Drugs Ltd.107.85172.95102.20
NIFTY(S&P CNX)304.15877.90486.75
BSE SENSEX1,143.203,278.042,258.87
BSE 500517.641,252.93682.71

Corporate Details

Key Personal
No Data Available
Key Address
Registered Office
Plot No. N-198 MIDC Tarapur Village - Pamtermbhi,Palghar District,Maharashtra

Tel:022-24072249 24019025, Fax:022-24073462 25653234

investorrelations@aartidrugs.com
http://www.aartidrugs.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park L.B.S. Marg Vikhroli (West)
QUICK LINKS
RELIGARE ONLINE
IMPORTANT LINKS
EXPLORE RELIGARE
Stocks Directory
Mutual Funds Directory
Investor Complaints
Attention Investors

Prevent unauthorized transactions in your account - Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day - Issued in the interest of Investors.

Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Depository (NSDL/CDSL) on the same day issued in the interest of investors.

Filing complaint on SEBI SCORES – Easy & quick
a. Register on SCORES portal
b. Mandatory details for filing complaints on SCORES - Name, PAN, Address, Mobile Number, E-mail ID
c. Benefits - Effective Communication & speedy redressal of the grievances

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investors account.

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Trading and Demat Accounts opened under Insta Plan will not be eligible for dealing through branches.

Kindly update your aadhar with us here. UPDATE AADHAAR
Follow us on
Unified Portal Version No.1.0.0.1
Copyright 2010 Religare. Trademarks are the property of their respective owners. All rights reserved.
Religare Broking Limited, Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
Broking Business of Religare Securities Ltd ( RSL) has been transferred and vested in Religare Broking Limited ( RBL) , pursuant to NCLT order.
  • Religare Broking Limited (RBL) :
  • SEBI Regn. No. INZ000174330 NSE CM, F&O, CD TM Code: 06537 Clearing Member (F&O) No. M50235; BSE CM, F&O,CD, CO Code: 3004 Clearing No: 3004 MSEI CM, F&O, CD, TM Code: 1051 Clearing Member No. 51  | MCX Membership No. 56560 | NCDEX Membership No. 01276 | AMFI ARN No.139809.
  • Depository Participant –
  • NSDL: DP ID: IN 301774  |  SEBI Regn. No: IN-DP-385-2018  |  CDSL DP ID: 30200  |  SEBI Regn. No: IN-DP-385-2018
  • Religare Broking Limited (RBL):
  • Research Analyst SEBI Regi. No.: INH100006977
    Religare Commodities Limited- Registered Office:2nd Floor, Rajlok Building, 24, Nehru Place, New Delhi-110019. Board line number 011-46272400, Fax No. 011-46272447
  • Member :
  • NCDEX: Member ID - 00109 |
  • MCX: Member ID - 10575 |
  • SEBI Registration Number- INZ000022334|
  • NSEL Member ID- 10180 |
  • Neml Member ID - 10042
The Site is best viewed with screen resolution 1024x768. The compatible browsers are Mozilla Firefox, Google Chrome and IE 8 (or above)